<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02129270</url>
  </required_header>
  <id_info>
    <org_study_id>158-13-EMC</org_study_id>
    <nct_id>NCT02129270</nct_id>
  </id_info>
  <brief_title>Hematoma Block for Reduction of Distal Radius Fractures</brief_title>
  <official_title>Phase 4 Study of Hematoma Block for Reduction of Distal Radius Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to Prove that injection of 15 to 20 mL of lidocaine 1% into the
      fracture site (Hematoma block) is more effective in terms of pain relieving then injection of
      10 mL of lidocaine 2%, and equally safe in terms of complications, for closed reduction of
      distal radius fractures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Actual">August 2018</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>This study will be measured effective in terms of pain relieving with Visual Analog Scale.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>This study will be measured safe in terms of complications to injection.</measure>
    <time_frame>1 year</time_frame>
    <description>Number of Participants with Adverse Events as a Measure of Safety and Tolerability.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Fractures of the Distal Radius</condition>
  <arm_group>
    <arm_group_label>Lidocaine HCl 2%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine HCl 2% (200mg/10ml) 10 ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine HCl 1%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine HCl 1% (100mg/10ml) 15-20 ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine HCl 2% .</intervention_name>
    <description>comparison of different dosages of drug</description>
    <arm_group_label>Lidocaine HCl 2%</arm_group_label>
    <other_name>ESRACAIN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine HCl 1%</intervention_name>
    <description>comparison of different dosages of drug</description>
    <arm_group_label>Lidocaine HCl 1%</arm_group_label>
    <other_name>ESRACAIN</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Fractures of the distal radius, with or without ulna fracture

        Exclusion Criteria:

          -  Children,

          -  pregnant women,

          -  patients with infection or suspected infection on the site for injection.

          -  Patients whose condition requires general anesthesia (patients with more fractures
             other than the distal radius and ulna, patients with many damage...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nimrod Rozen, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEemek Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HaEmek medical center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2014</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fractures of the distal radius</keyword>
  <keyword>Hematoma block</keyword>
  <keyword>Lidocaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Radius Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

